Conference paper

Targets for the Treatment of Breast Cancer

E. A. G. Blomme
F. Del Piero
K. L. Kolaja

Abstract

The completion of the human genome sequence provides unique opportunities to identify new molecular targets for a variety of diseased conditions, especially for neoplastic diseases. Breast cancer is an ideal disease for the implementation of the recently developed, sophisticated genomic technologies, which permit the study of expression of many genes or proteins simultaneously, an approach known as molecular profiling. This approach is considered a major step forward in the development of new drugs that are more effective and less toxic than the current generation of antitumor agents. In this paper, we briefly review the current and future genomics technologies, such as DNA microarrays and proteomics techniques, and their use in the identification of new molecular targets for the treatment of breast cancer. We also discuss the challenge associated with the development of bioinformatics tools to analyze the massive number of data points generated by these technologies. Proof of principle is now emerging, demonstrating that selective agents against abnormal or mutated gene products can indeed be useful in the treatment of cancer. However, despite heavy investment in genomics research by the pharmaceutical industry, the full impact of genomics on drug discovery has yet to be fully demonstrated.

Keywords

Genomics; Microarrays; Proteomics; Molecular target

Hrčak ID:

15169

URI

https://hrcak.srce.hr/15169

Publication date:

3.6.2002.

Visits: 1.213 *